Microwave-induced in situ amorphization: mechanistic basis, formulation principles, and translational perspective
4 affiliations
- 1College of Pharmacy, Mokpo National University, Muan, Jeonnam-Gwangju, 58554, Republic of Korea
- 2College of Pharmacy, Daegu Catholic University, Gyeongsan–si, Gyeongbuk, 38430, Republic of Korea
- 3College of Pharmacy, Yonsei University, Incheon, 21983, Republic of Korea
- 4Department of Biomedicine, Health & Life Convergence Sciences, BK21 Four, Biomedical and Healthcare Research Institute, Mokpo National University, Muan, Jeonnam-Gwangju, 58554, Republic of Korea
Abstract
Although amorphous solid dispersions (ASDs) improve the oral delivery of drugs with poor water-solubility, their broader application is limited by the physical instability of the amorphous state and challenges associated with the downstream processing of metastable materials. Microwave-induced in situ amorphization provides an alternative route to ASD formation by maintaining the drug in a crystalline form before microwave treatment and inducing amorphous conversion within the prepared dosage form. This review traces the development of the approach and integrates mechanistic understanding with the formulation and process factors governing its performance. Available evidence indicates that amorphization proceeds primarily through drug dissolution into a transiently mobile carrier phase, rather than direct melting of the crystalline drug. Successful conversion and retention of the amorphous state require coordinated dielectric activation, carrier mobility, and post-amorphization stabilization. The overall performance depends on drug and excipient properties, moisture content, compact structure, and microwave conditions. To facilitate practical implementation, recent formulation strategies have broadened the available activation routes and reduced reliance on external humidity conditioning. Microwave-induced in situ amorphization may therefore complement conventional ASD manufacturing, particularly when storage or downstream processing of metastable amorphous systems remains challenging.
Related
- Ethosomal drug delivery systems for skin cancer: Mechanistic insights, formulation strategies, and translational challenges.
- Formononetin as a Natural Product-Derived Candidate for Diabetic Microvascular Complications: Mechanistic Evidence, Pharmacokinetics, Formulation Strategies, and Translational Barriers
- Pstpip2-deficient mouse models in SAPHO syndrome research: Utility, mechanistic insights, and translational limitations
- Ursolic acid as a multi-target therapeutic candidate in type 2 diabetes mellitus: a mechanistic and translational review
- Enterovirus 2B protein: From viroporin to membrane stress sensor, mechanistic principles of multi-pathway regulation.
BibTeX
@article{suwal2026microwaveinduced,
title = {{Microwave-induced in situ amorphization: mechanistic basis, formulation principles, and translational perspective}},
author = {Kiran Suwal and Du Hyung Choi and Ji Min Choi and Seong Hoon Jeong and Nam Ah Kim and Ki Hyun Kim},
journal = {International Journal of Pharmaceutics: X},
year = {2026},
month = oct,
doi = {10.1016/j.ijpx.2026.100696},
url = {https://doi.org/10.1016/j.ijpx.2026.100696},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Microwave-induced in situ amorphization: mechanistic basis, formulation principles, and translational perspective
AU - Kiran Suwal
AU - Du Hyung Choi
AU - Ji Min Choi
AU - Seong Hoon Jeong
AU - Nam Ah Kim
AU - Ki Hyun Kim
PY - 2026
DA - 2026/10/22
JO - International Journal of Pharmaceutics: X
DO - 10.1016/j.ijpx.2026.100696
UR - https://doi.org/10.1016/j.ijpx.2026.100696
AB - Although amorphous solid dispersions (ASDs) improve the oral delivery of drugs with poor water-solubility, their broader application is limited by the physical instability of the amorphous state and challenges associated with the downstream processing of metastable materials. Microwave-induced in situ amorphization provides an alternative route to ASD formation by maintaining the drug in a crystalline form before microwave treatment and inducing amorphous conversion within the prepared dosage form. This review traces the development of the approach and integrates mechanistic understanding with the formulation and process factors governing its performance. Available evidence indicates that amorphization proceeds primarily through drug dissolution into a transiently mobile carrier phase, rather than direct melting of the crystalline drug. Successful conversion and retention of the amorphous state require coordinated dielectric activation, carrier mobility, and post-amorphization stabilization. The overall performance depends on drug and excipient properties, moisture content, compact structure, and microwave conditions. To facilitate practical implementation, recent formulation strategies have broadened the available activation routes and reduced reliance on external humidity conditioning. Microwave-induced in situ amorphization may therefore complement conventional ASD manufacturing, particularly when storage or downstream processing of metastable amorphous systems remains challenging.
SN - 2590-1567
ER -